Tokyo based Boutique equity research house Koyal Group, today announced the appointment of Dr Matthew James to the position of Chief Investment Officer for the company's Asian operations.
Chief Executive Officer at Tokyo based equity research house Koyal Group, Mr Edward Neilson, announced at 9.30am Japanese time the appointment of long term employee Dr Matthew James to the position of Chief Investment Officer for the company's Asian operations. Dr James will replace retiring Chief Investment Officer at Koyal Group, Mr William Young MSc, who has been with the company since 2007. Additionally Dr James is expected to undertake the Chief Investment Officer role, for the company's operations outside Asia over the course of 2013-2014.
Dr Matthew James (53) holds both a master's degree in business administration and a doctorate in finance and economics, and has worked as an analyst at Koyal Group since 2004 when he joined Koyal Group from his previous position with investment bank Mitsubishi UFJ. According to Chief Executive officer at Koyal Group Mr Edward Neilson, Dr James today signed a ten year contract with Koyal Group where he intends to see out the remainder of his career prior to his planned retirement at sixty three years of age.
"Dr Matthew James has earned his position as Chief Investment Officer within our company, and I am absolutely confident in the decision of our board to appoint him to that position."
- Chief Executive Officer Edward Neilson.
Head of Investment Analysis at Koyal Group, Mr Nathan Andrews also commented on the appointment of Dr James saying, "Having supervised Dr James for the past seven years since he joined us here at Koyal Group, I can confidently say that he is the ideal candidate to fill the void left by Mr Young, and I look forward to working closely with in his new role".
Dr James' new role as Chief Investment Officer will mean he is now responsible for managing the Koyal Group asset portfolio, devising investment strategies, and assessing and managing risk.